BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//www.barthsyndrome.org//NONSGML kigkonsult.se iCalcreator 2.30.10/
 /
CALSCALE:GREGORIAN
METHOD:PUBLISH
UID:e5c53f19-144d-48d3-912c-259ad627e433
X-WR-CALDESC:Given the complexities of primary mitochondrial diseases and\,
  by extension\, the challenges of designing informative clinical trials in
  this group of rare diseases\, this scientific symposium will bring togeth
 er academic physicians\, FDA regulatory experts\, and experts from related
  disciplines to exchange ideas on ways to address the challenges and to pr
 omote drug development in this challenging field.  BSF Executive Director\
 , Emily Milligan will be speaking as a member of the second panel discussi
 on.
X-WR-RELCALID:db43ce511ad68c95e6070fa8c28f97f6
X-WR-TIMEZONE:America/New_York
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:STANDARD
TZNAME:EST
DTSTART:20181104T020000
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
RDATE:20191103T020000
RDATE:20201101T020000
END:STANDARD
BEGIN:DAYLIGHT
TZNAME:EDT
DTSTART:20190310T020000
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
RDATE:20200308T020000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
UID:a29b949f-ff07-4358-ba74-39c941447f44
DTSTAMP:20260429T045339Z
DESCRIPTION:Given the complexities of primary mitochondrial diseases and\, 
 by extension\, the challenges of designing informative clinical trials in 
 this group of rare diseases\, this scientific symposium will bring togethe
 r academic physicians\, FDA regulatory experts\, and experts from related 
 disciplines to exchange ideas on ways to address the challenges and to pro
 mote drug development in this challenging field.  BSF Executive Director\,
  Emily Milligan will be speaking as a member of the second panel discussio
 n.
DTSTART;TZID=America/New_York:20190906T080000
DTEND;TZID=America/New_York:20190906T160000
LOCATION:
SUMMARY:Developing Therapies for Primary Mitochondrial Diseases: Bridging t
 he Gaps (US-FDA)
END:VEVENT
END:VCALENDAR